Skip to contentTomasello Shawn — Kite Pharma, Inc. insider: 79 transactions · InsiderLensTomasello Shawn
- Director at Cabaletta Bio, Inc. · on record since Jun 10, 2026
- Chief Commercial Officer at PHARMACYCLICS INC · on record since Aug 19, 2014
- Chief Commercial Officer at Kite Pharma, Inc. · on record since Dec 21, 2015
- Director at Diplomat Pharmacy, Inc. · on record since Oct 9, 2015
- Director at UroGen Pharma Ltd. · on record since Jan 10, 2019
- Director at Principia Biopharma Inc. · on record since Aug 30, 2019
- Director at ACCESS PHARMACEUTICALS INC · on record since May 22, 2020
- Director at 4D Molecular Therapeutics, Inc. · on record since Dec 10, 2020
- Director at TCR2 THERAPEUTICS INC. · on record since Feb 4, 2021
- Director at Kalaris Therapeutics, Inc. · on record since Mar 31, 2022
- Director at Gamida Cell Ltd. · on record since Jan 3, 2022
Insider trading activity of Tomasello Shawn
- Transactions on record
- 79
- since Aug 19, 2014
- Open-market buys
- 2
- $65.2K
- Open-market sells
- 5
- $1.1M
- Companies traded
- 11
- last filing Jun 18, 2026
Figures computed from official regulatory filings — methodology.
Companies where Tomasello Shawn has traded
- 4D Molecular Therapeutics, Inc.6 tx · Jun 18, 2026
- Cabaletta Bio, Inc.9 tx · $50.2K · Jun 10, 2026
- Kalaris Therapeutics, Inc.4 tx · Jun 7, 2024
- Gamida Cell Ltd.10 tx · $15K · Feb 2, 2024
- TCR2 THERAPEUTICS INC.8 tx · Jun 1, 2023
- UroGen Pharma Ltd.3 tx · Jun 9, 2021
- Principia Biopharma Inc.4 tx · Sep 28, 2020
- ACCESS PHARMACEUTICALS INC2 tx · May 22, 2020
- Diplomat Pharmacy, Inc.11 tx · $229.3K · Feb 10, 2020
Track record of Tomasello Shawn
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Tomasello Shawn
Co-insiders of Tomasello Shawn
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
13 tx · $14.7M · Oct 5, 2017
BIOTECHNOLOGY VALUE FUND L P4D Molecular Therapeutics, Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 18, 2026 | AwardD | 50,000 | 0.00 USD | — | SEC |
| Jun 10, 2026 | AwardD | 22,000 | 0.00 USD | $0 | SEC |
| Jan 21, 2026 | Buy | 22,725 | 2.21 USD | $50.2K | SEC |
| Jun 20, 2025 | AwardD | 22,500 | 0.00 USD | $0 | SEC |
| Jun 9, 2025 | AwardD | 22,000 | 0.00 USD | $0 | SEC |
| May 19, 2025 | AwardD | 22,000 | 0.00 USD | $0 | SEC |
| May 19, 2025 | OtherD | -44,000 | 0.00 USD | $0 | SEC |
| May 19, 2025 | OtherD | -22,000 | 0.00 USD | $0 | SEC |
| May 19, 2025 | AwardD | 44,000 | 0.00 USD | $0 | SEC |
| Jun 7, 2024 | Award | 35,000 | 0.00 USD | $0 | SEC |
| Jun 4, 2024 | AwardD | 22,000 | 0.00 USD | $0 | SEC |
| May 23, 2024 | AwardD | 22,500 | 0.00 USD | $0 | SEC |
| Feb 2, 2024 | Award | 200,000 | 0.00 USD | $0 | SEC |
| Oct 20, 2023 | AwardD | 17,000 | 0.00 USD | $0 | SEC |
| Oct 20, 2023 | Award | 28,300 | 0.00 USD | $0 | SEC |
| Oct 20, 2023 | AwardD | 56,600 | 0.00 USD | $0 | SEC |
| Jul 24, 2023 | AwardD | 44,000 | 0.00 USD | $0 | SEC |
| Jun 1, 2023 | OtherD | -16,800 | 0.00 USD | $0 | SEC |
| Jun 1, 2023 | OtherD | -12,100 | 0.00 USD | $0 | SEC |
| Jun 1, 2023 | OtherD | -15,191 | 0.00 USD | $0 | SEC |
| Jun 1, 2023 | OtherD | -4,177 | 0.00 USD | $0 | SEC |
| May 25, 2023 | AwardD | 22,500 | 0.00 USD | $0 | SEC |
| May 12, 2023 | Award | 35,000 | 0.00 USD | $0 | SEC |
| Mar 22, 2023 | AwardD | 17,000 | 0.00 USD | $0 | SEC |
| Feb 10, 2023 | AwardD | 56,600 | 0.00 USD | $0 | SEC |